Latest news with #Cumulus
The Hindu
4 days ago
- Entertainment
- The Hindu
Museum of Art & Photography installations to be exhibited at KIA Bengaluru
The Kempegowda International Airport (KIA) has partnered with the Museum of Art & Photography (MAP), Bengaluru to offer passengers a unique cultural experience in its Terminal 2 (T2). The Bangalore International Airport Limited (BIAL) which operates KIA, stated that this collaboration aims to transform the airport into a dynamic cultural hub, allowing travellers to engage with the rich tapestry of South Asian art and heritage during their journeys. Through thoughtfully curated interactive installations, featuring the works of celebrated artists, passengers will have the opportunity to explore and connect with the region's diverse creative legacy. T2 is already home to a collection of 210 carefully curated artworks by more than 60 artists. What can passengers explore? At T2's domestic terminal, passengers can enjoy a suite of immersive digital experiences curated by MAP which include: Gallery on Demand – Step into a world of artistic exploration with a rich digital library featuring works by renowned artists such as Jamini Roy, Jangarh Singh Shyam, Jyoti Bhatt, Suresh Punjabi, and L.N. Tallur. The platform also brings MAP's extensive film ephemera collection to life through curated stories built around Bollywood posters, stills, and lobby cards. From tracing the evolution of the tawaif figure to embarking on a journey through Arabian Nights, these narratives captivate and inform. A series of short films further offers intimate insights into the lives and practices of selected artists from the MAP collection. Interactive Puzzles – Engage with iconic artworks like Universe by S.H. Raza, Last Supper by Jamini Roy, and The Lotus Sellers by N.S. Bendre through touch-based puzzles that make art both playful and thought-provoking. Digital Lamp Lighting – Rooted in Indian tradition, lighting a lamp marks the beginning of something auspicious. This interactive feature lets travellers digitally light a lamp from MAP's collection by scanning a QR code and personalising the moment with their name — a small but meaningful pause in the journey. Cumulus – Digital Collection Viewing System – Dive deep into MAP's digitised archive using Cumulus, an intuitive application that lets users search, zoom, curate, and share artefacts. With tools for closer inspection and personal collection building, it's an ideal gateway for both casual discovery and deeper research. Virtual Greetings – Send animated digital festival and occasion-based greetings inspired by artworks in MAP's collection. Travellers can also explore an exclusive retail zone featuring MAP collection-inspired home and lifestyle products — ideal for souvenirs, gifts, or a personal piece of art to take home. T2's international terminal will host an exhibition 'Bhuri Bai: My Life as an Artist', spotlighting the journey of Padma Shri awardee Bhuri Bai. Hari Marar, MD & CEO, Bangalore International Airport Limited (BIAL), said, 'At KIA, we're reimagining what it means to travel — not just as a journey from one place to another, but as an experience enriched by culture, creativity, and connection. Our collaboration with MAP is a step in realising that vision, aiming to transform Terminal 2 into a vibrant hub of discovery and engagement. By bringing art into the passenger journey in such an accessible and interactive way, we hope to offer travellers moments of pause, inspiration, and reflection. It's our way of weaving the cultural richness of the region into the overall airport experience.'
Associated Press
04-04-2025
- Business
- Associated Press
Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual Meeting
Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater separation with Alzheimer's pTau217 pathology than the benchmark Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) BELFAST, Northern Ireland, April 4, 2025 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® Platform validation data for two novel assessments of cognitive impairment in Alzheimer's dementia (AD), and proof-of-concept data in amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD) at the AD/PD™ 2025 in Vienna, Austria. 'We are excited to share data validating NeuLogiq Platform cognitive tasks to measure memory, executive function and psychomotor function in broader neurodegenerative indications. We also demonstrated sensitivity to underlying Alzheimer's pathology, correlating to plasma ptau217 status,' said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus. 'Additionally, our CNS-101 study demonstrated that patients could achieve high levels of adherence performing repeated cognitive and EEG tests at home to capture high quality data, making them suitable for use in clinical trials where precise measurement at the individual level is critical. Separately, data presented from our CNS-102 study provides proof-of-concept that NeuLogiq can capture data relevant in ALS-FTD, including patients with profound motor impairments. Collectively, these data confirm that the NeuLogiq Platform has the potential to enable earlier detection of disease and provide biopharma with longitudinal real-world data that can streamline clinical studies.' The first poster, titled 'Neuropsychological phenotyping of Alzheimer's dementia at home, using the Cumulus NeuLogiq Platform with plasma biomarkers,' featured data demonstrating that patients are willing and able to perform repeated cognitive and EEG testing at home, and the NeuLogiq Platform endpoints show greater separation with AD pathology (pTau217) than the benchmark endpoint (ADAS-Cog) throughout the study. Importantly, these endpoints accord with standard benchmarks and demonstrate patterns of patient impairment consistent with the literature. EEG biomarkers, including passive and task-based measures, demonstrate morphology and group differences as expected based on the literature. The second poster titled, 'Neurocognitive evaluation from the home: validation of the Cumulus Platform in FTD and ALS populations,' provided initial evidence that the NeuLogiq Platform can capture speech fluency and emotion recognition decline in patients living with ALS, offering potential utility as a digital biomarker of cognitive decline, in addition to providing proof-of-concept that the platform can capture meaningful neuropsychological data, relevant to the heterogeneity of the ALS-FTD phenotype. Cumulus continues to advance the NeuLogiq Platform, providing biopharma partners and collaborators with a suite of state-of-the-art tools to help advance the discovery and development of new therapies for neuropsychiatric and neurodegenerative conditions. To learn more, visit About Alzheimer's Disease and pTau217 Alzheimer's is a progressive disease that affects brain function, memory, and other cognitive abilities. It is the most common cause of dementia, affecting millions of people worldwide. Symptoms usually develop slowly and worsen over time, including memory loss, confusion, mood swings, changes in behavior and personality, and difficulty with language and communication. Currently, there is no known cure for Alzheimer's. Today, earlier diagnosis can enable patients to make lifestyle changes, including exercising and decreasing alcohol consumption, both of which have been shown to slow disease progression. In the future, having the ability to diagnose patients earlier may expedite enrollment in clinical studies and the identification of new treatments. pTau217, a phosphorylated fragment of the tau protein, is a promising blood-based biomarker for detecting Alzheimer's disease (AD) pathology, showing high accuracy in identifying amyloid and tau pathology, and potentially distinguishing AD from other neurodegenerative disorders. About Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) ALS and FTD are two neurodegenerative diseases that share some similarities but also have distinct characteristics. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to the loss of motor neuron function and eventually causing muscle weakness and paralysis. FTD involves the progressive degeneration of neurons in the areas of the brain behind the forehead (the frontal lobe) and behind the ears (the temporal lobes), leading to changes in personality, behavior, and language. About Cumulus Neuroscience Our mission is to generate the data and insights required to accelerate the diagnosis and management of central nervous system (CNS) disorders for millions of patients and caregivers around the world. At Cumulus Neuroscience, we are advancing NeuLogiq®, an AI-based, multi-domain digital biomarker platform designed with 10 of the world's leading pharma companies. This novel platform provides the critical data and insights needed for faster, more robust and cost-effective decision-making in clinical trials and patient care. NeuLogiq enables study sponsors to capture large amounts of real-world clinical data repeatedly over time, across multiple behavioral and physiological domains, in the clinic and at home. Together with machine learning (ML) analytics, Cumulus simplifies and improves the robustness of CNS clinical trials, providing objective assessment of study inclusion and treatment outcomes.
Yahoo
04-04-2025
- Business
- Yahoo
Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual Meeting
Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater separation with Alzheimer's pTau217 pathology than the benchmark Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) BELFAST, Northern Ireland, April 4, 2025 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® Platform validation data for two novel assessments of cognitive impairment in Alzheimer's dementia (AD), and proof-of-concept data in amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD) at the AD/PD™ 2025 in Vienna, Austria. "We are excited to share data validating NeuLogiq Platform cognitive tasks to measure memory, executive function and psychomotor function in broader neurodegenerative indications. We also demonstrated sensitivity to underlying Alzheimer's pathology, correlating to plasma ptau217 status," said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus. "Additionally, our CNS-101 study demonstrated that patients could achieve high levels of adherence performing repeated cognitive and EEG tests at home to capture high quality data, making them suitable for use in clinical trials where precise measurement at the individual level is critical. Separately, data presented from our CNS-102 study provides proof-of-concept that NeuLogiq can capture data relevant in ALS-FTD, including patients with profound motor impairments. Collectively, these data confirm that the NeuLogiq Platform has the potential to enable earlier detection of disease and provide biopharma with longitudinal real-world data that can streamline clinical studies." The first poster, titled "Neuropsychological phenotyping of Alzheimer's dementia at home, using the Cumulus NeuLogiq Platform with plasma biomarkers," featured data demonstrating that patients are willing and able to perform repeated cognitive and EEG testing at home, and the NeuLogiq Platform endpoints show greater separation with AD pathology (pTau217) than the benchmark endpoint (ADAS-Cog) throughout the study. Importantly, these endpoints accord with standard benchmarks and demonstrate patterns of patient impairment consistent with the literature. EEG biomarkers, including passive and task-based measures, demonstrate morphology and group differences as expected based on the literature. The second poster titled, "Neurocognitive evaluation from the home: validation of the Cumulus Platform in FTD and ALS populations," provided initial evidence that the NeuLogiq Platform can capture speech fluency and emotion recognition decline in patients living with ALS, offering potential utility as a digital biomarker of cognitive decline, in addition to providing proof-of-concept that the platform can capture meaningful neuropsychological data, relevant to the heterogeneity of the ALS-FTD phenotype. Cumulus continues to advance the NeuLogiq Platform, providing biopharma partners and collaborators with a suite of state-of-the-art tools to help advance the discovery and development of new therapies for neuropsychiatric and neurodegenerative conditions. To learn more, visit About Alzheimer's Disease and pTau217Alzheimer's is a progressive disease that affects brain function, memory, and other cognitive abilities. It is the most common cause of dementia, affecting millions of people worldwide. Symptoms usually develop slowly and worsen over time, including memory loss, confusion, mood swings, changes in behavior and personality, and difficulty with language and communication. Currently, there is no known cure for Alzheimer's. Today, earlier diagnosis can enable patients to make lifestyle changes, including exercising and decreasing alcohol consumption, both of which have been shown to slow disease progression. In the future, having the ability to diagnose patients earlier may expedite enrollment in clinical studies and the identification of new treatments. pTau217, a phosphorylated fragment of the tau protein, is a promising blood-based biomarker for detecting Alzheimer's disease (AD) pathology, showing high accuracy in identifying amyloid and tau pathology, and potentially distinguishing AD from other neurodegenerative disorders. About Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) ALS and FTD are two neurodegenerative diseases that share some similarities but also have distinct characteristics. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to the loss of motor neuron function and eventually causing muscle weakness and paralysis. FTD involves the progressive degeneration of neurons in the areas of the brain behind the forehead (the frontal lobe) and behind the ears (the temporal lobes), leading to changes in personality, behavior, and language. About Cumulus Neuroscience Our mission is to generate the data and insights required to accelerate the diagnosis and management of central nervous system (CNS) disorders for millions of patients and caregivers around the world. At Cumulus Neuroscience, we are advancing NeuLogiq®, an AI-based, multi-domain digital biomarker platform designed with 10 of the world's leading pharma companies. This novel platform provides the critical data and insights needed for faster, more robust and cost-effective decision-making in clinical trials and patient care. NeuLogiq enables study sponsors to capture large amounts of real-world clinical data repeatedly over time, across multiple behavioral and physiological domains, in the clinic and at home. Together with machine learning (ML) analytics, Cumulus simplifies and improves the robustness of CNS clinical trials, providing objective assessment of study inclusion and treatment outcomes. FOR MORE INFORMATIONTina Tel: 415.694.1175 Logo: View original content: Sign in to access your portfolio
Associated Press
13-02-2025
- Business
- Associated Press
Switzerland Loyalty Programs Market Intelligence Report 2025-2029: Migros (Cumulus), Coop (Supercard), and Swiss Miles & More Leveraging Strong Ecosystems and Brand Trust to Maintain Market Leadership
The 'Switzerland Loyalty Programs Market Intelligence and Future Growth Dynamics - 50+ KPIs on Loyalty Programs Trends by End-Use Sectors, Operational KPIs, Retail Product Dynamics, and Consumer Demographics - Q1 2025 Update' report has been added to offering. The loyalty market in Switzerland is expected to grow by 14.8% on annual basis to reach US$525.9 million in 2025. In value terms, the loyalty market in the country has recorded a CAGR of 16.6% during 2020-2024. The loyalty market in the country will continue to grow over the forecast period and is expected to record a CAGR of 12.4% during 2025-2029. Loyalty market in this region is expected to increase from US$458.1 million in 2024 to reach US$838.4 million by 2029. This report provides a detailed data-centric analysis of the loyalty market opportunities and risks across a range of end-use sectors and market segments in Switzerland. With over 50 KPIs at the country level, this report provides a comprehensive understanding of loyalty market dynamics, market size and forecast, and market share statistics. The loyalty program landscape in Switzerland is evolving in response to shifting consumer preferences, technological advancements, and societal priorities. Digital integration is reshaping how loyalty programs operate, offering convenience and personalized engagement through mobile apps and AI-driven systems. Simultaneously, sustainability is becoming a core element of loyalty strategies, aligning with Switzerland's environmental goals and the eco-conscious mindset of its population. Hyper-personalization, driven by data analytics and AI, is emerging as a critical differentiator for businesses seeking to build deeper connections with customers. Partnership-driven ecosystems enhance value by enabling cross-sector reward redemption and creating seamless loyalty experiences. Meanwhile, subscription-based loyalty programs are gaining traction, reflecting Swiss consumers' willingness to invest in premium, convenience-driven benefits. These trends are expected to intensify over the next 2-4 years as companies compete to deliver innovative, customer-centric loyalty programs. Businesses that strategically integrate these trends into their offerings will enhance customer retention and strengthen their market positioning in Switzerland's competitive loyalty landscape. Competitive Landscape and Regulatory Changes in Switzerland's Loyalty Market The Swiss loyalty market is defined by moderate competitive intensity, with dominant players like Migros (Cumulus), Coop (Supercard), and Swiss Miles & More leveraging strong ecosystems and brand trust to maintain market leadership. At the same time, smaller players, such as regional grocery chains and niche service providers, contribute to market fragmentation, creating a dynamic but challenging landscape. High consumer loyalty toward established brands and the growing need for advanced digital capabilities pose significant entry barriers for new players. Over the next 2-4 years, the competitive landscape is expected to evolve, with leading players consolidating their market positions through partnerships and ecosystem expansion. Emerging niche programs focusing on sustainability and hyper-personalization will differentiate themselves in specific segments, while cross-industry collaboration will further reshape the market. Stricter regulatory changes, such as the revised Federal Act on Data Protection (FADP), will require loyalty operators to enhance data privacy and compliance frameworks, increasing operational costs but ensuring greater transparency and trust. Companies that can adapt to these competitive and regulatory dynamics will have a significant advantage in Switzerland's loyalty market. Growing Integration of Digital Platforms in Loyalty Programs Swiss companies increasingly leverage digital platforms like mobile apps and online portals to deliver loyalty program services. Retailers like Migros and Coop have introduced app-based loyalty programs where customers can track points, redeem rewards, and access personalized offers through their smartphones. For example, Migros' Cumulus program has gained significant traction as one of the largest loyalty ecosystems in Switzerland, allowing users to access their rewards digitally. The rise in e-commerce penetration in Switzerland, coupled with high smartphone adoption rates (around 90% of the population uses smartphones), is driving companies to prioritize digital solutions. Furthermore, consumer expectations for convenience and personalization are prompting businesses to offer seamless, tech-enabled loyalty experiences. Digital integration is expected to intensify as businesses in retail, travel, and financial services invest further in AI-driven personalization and real-time reward systems. By 2027, nearly all major loyalty programs in Switzerland will offer full digital accessibility, contributing to increased consumer engagement and retention. Focus on Sustainability as a Loyalty Driver Swiss loyalty programs are increasingly tying rewards to sustainability initiatives. For example, Coop's Supercard program allows customers to donate rewards to support environmental causes or purchase eco-friendly products. Additionally, brands like IKEA Switzerland have introduced loyalty benefits that align with eco-conscious shopping habits, such as discounts on sustainable goods. Switzerland's reputation as a leader in sustainability and its environmentally aware consumer base have propelled companies to embed green initiatives into loyalty programs. The Swiss government's push toward achieving carbon neutrality by 2050 has further encouraged corporations to align with sustainable practices, including loyalty-driven incentives for green behavior. Sustainability-focused loyalty programs are expected to increase in popularity as businesses compete to demonstrate their commitment to environmental goals. Companies integrating such elements into their programs will likely see stronger brand loyalty among eco-conscious Swiss consumers. Shift Toward Hyper-Personalization in Rewards Personalized rewards based on individual consumer preferences are becoming a key focus for Swiss loyalty programs. For example, the Swiss Travel System's loyalty program tailors discounts and offers for frequent travelers based on their travel habits. Similarly, retailers like Migros use customer data to curate customized product recommendations and exclusive offers. The growing availability of advanced analytics and AI technologies has enabled businesses to analyze customer data more effectively. At the same time, Swiss consumers strongly prefer experiences and products that cater to their specific needs, making personalization a competitive advantage. Hyper-personalization is expected to dominate loyalty program strategies, especially in retail, travel, and financial services sectors. Programs that fail to offer personalized rewards risk losing relevance, while those that excel in this area will likely see improved customer retention and increased spending. Partnership-Driven Loyalty Ecosystems Swiss companies are increasingly forming partnerships to create interconnected loyalty ecosystems. For instance, the collaboration between Cumulus and MBudget Mobile enables customers to earn loyalty points on mobile services. Another example is Swiss Miles & More, which integrates rewards across multiple sectors, including airlines, hotels, and car rentals. Companies' efforts to expand the value proposition of their loyalty programs are fueling cross-industry collaboration. Consumers are drawn to ecosystems that allow them to accumulate and redeem rewards across multiple touchpoints, making such programs more attractive. Partnership-driven loyalty ecosystems are anticipated to grow as businesses explore synergies with complementary industries. This trend will likely boost customer retention across sectors while providing consumers a unified and valuable loyalty experience. Adoption of Subscription-Based Loyalty Programs Subscription-based loyalty models are gaining momentum in Switzerland, where customers pay a fee for premium benefits. For example, Amazon Prime Switzerland offers subscribers faster delivery, streaming services, and exclusive deals. Similarly, local retailers are exploring subscription-style memberships that provide perks like unlimited free deliveries or exclusive access to sales. The growth of the subscription economy and the demand for premium customer experiences are driving this trend. Swiss consumers are willing to pay for added convenience and unique benefits, particularly in sectors like e-commerce and streaming. Subscription-based loyalty programs will likely be widely adopted, especially among e-commerce players and premium service providers. This trend will enable businesses to secure predictable revenue streams while fostering a deeper connection with loyal customers. Market Structure While dominant players control a significant market share, the landscape remains moderately fragmented. This fragmentation is evident in specific sectors, such as retail and hospitality, where regional players operate alongside national giants. For example, loyalty programs like IKEA Family Switzerland and Payback Switzerland coexist with the more widespread programs of Migros and Coop. Swiss consumers often show strong loyalty to established brands, making it challenging for new entrants to establish themselves. Advanced digital capabilities, such as AI-driven personalization and seamless app functionality, are now prerequisites for competing in the loyalty market. New entrants must make significant investments to meet these expectations. Switzerland's robust consumer data protection laws, including adherence to the Swiss Federal Act on Data Protection (FADP) and GDPR-equivalent regulations, add complexity to market entry. Expected Evolution of Competitive Landscape (Next 2-4 Years) Larger players are expected to consolidate their positions through expanded offerings and partnerships. For instance, Migros and Coop may further enhance their ecosystems by integrating with fintech services or mobility solutions, making it harder for smaller players to compete. Niche loyalty programs targeting specific demographics or preferences (e.g., sustainability-focused programs or luxury travel rewards) will likely emerge as differentiators in a competitive market. Cross-industry partnerships will likely become more prominent, with sectors like financial services, retail, and travel collaborating to create integrated loyalty ecosystems. The competitive edge will increasingly depend on leveraging AI, blockchain for secure transactions, and real-time data analytics to enhance program efficiency and customer satisfaction. Key Attributes: Report Attribute Details No. of Pages 130 Forecast Period 2025 - 2029 Estimated Market Value (USD) in 2025 $525.9 Million Forecasted Market Value (USD) by 2029 $838.4 Million Compound Annual Growth Rate 12.4% Regions Covered Switzerland For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Copyright Business Wire 2025. PUB: 02/13/2025 11:45 AM/DISC: 02/13/2025 11:45 AM
